The steerer tube collar on the affected products may crack if exposed to corrosion which may cause the rider to loose control, posing fall and injury hazards.
As of December 18, 2018, the company has not received any reports of incidents in Canada, and no report of injuries.
FDA - U.S. Food and Drug Administration
The European Medicines Agency has reviewed the adverse events of Bravecto®, a veterinary medicine used to treat flea and tick infestations in dogs. The conclusion is that the medicine may on very rare occasions cause convulsions in dogs – primarily in dogs with pre-existing epilepsy.
Danish Medicines Agency
There are no news related to this product.